LivaNova (LIVN) Capital Expenditures Growth (5y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.69% |
| Dec 31, 2025 | 37.41% |
| Sep 30, 2025 | 16.88% |
| Jun 30, 2025 | 10.11% |
| Mar 31, 2025 | 4.65% |
| Dec 31, 2024 | 5.69% |
| Sep 30, 2024 | 24.76% |
| Jun 30, 2024 | 19.18% |
| Mar 31, 2024 | 2.19% |
| Dec 31, 2023 | 0.08% |
| Sep 30, 2023 | -5.93% |
| Jun 30, 2023 | -3.15% |
| Mar 31, 2023 | 5.62% |
| Dec 31, 2022 | 0.46% |
| Sep 30, 2022 | -7.83% |
| Jun 30, 2022 | -3.59% |
| Mar 31, 2022 | -7.17% |
| Dec 31, 2021 | -4.27% |
| Sep 30, 2021 | -23.24% |
| Mar 31, 2021 | 0.20% |